BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37543157)

  • 1. Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory G-protein coupled receptor GPR84.
    Luscombe VB; Baena-López LA; Bataille CJR; Russell AJ; Greaves DR
    Eur J Pharmacol; 2023 Oct; 956():175960. PubMed ID: 37543157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonists for G-protein-coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro-inflammatory responses in microglia.
    Wei L; Tokizane K; Konishi H; Yu HR; Kiyama H
    J Neuroinflammation; 2017 Oct; 14(1):198. PubMed ID: 28974234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxycarboxylic acid receptor 3 and GPR84 - Two metabolite-sensing G protein-coupled receptors with opposing functions in innate immune cells.
    Peters A; Rabe P; Liebing AD; Krumbholz P; Nordström A; Jäger E; Kraft R; Stäubert C
    Pharmacol Res; 2022 Feb; 176():106047. PubMed ID: 34968686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-phagocytic function and structural basis of GPR84 signaling.
    Zhang X; Wang Y; Supekar S; Cao X; Zhou J; Dang J; Chen S; Jenkins L; Marsango S; Li X; Liu G; Milligan G; Feng M; Fan H; Gong W; Zhang C
    Nat Commun; 2023 Sep; 14(1):5706. PubMed ID: 37709767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84.
    Marsango S; Barki N; Jenkins L; Tobin AB; Milligan G
    Br J Pharmacol; 2022 Jul; 179(14):3529-3541. PubMed ID: 32869860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-phagocytic function and structural basis of GPR84 signaling.
    Zhang X; Wang Y; Supekar S; Cao X; Zhou J; Dang J; Chen S; Jenkins L; Marsango S; Li X; Liu G; Milligan G; Feng M; Fan H; Gong W; Zhang C
    Res Sq; 2023 Feb; ():. PubMed ID: 36824923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor.
    Suzuki M; Takaishi S; Nagasaki M; Onozawa Y; Iino I; Maeda H; Komai T; Oda T
    J Biol Chem; 2013 Apr; 288(15):10684-91. PubMed ID: 23449982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20 Years an Orphan: Is GPR84 a Plausible Medium-Chain Fatty Acid-Sensing Receptor?
    Luscombe VB; Lucy D; Bataille CJR; Russell AJ; Greaves DR
    DNA Cell Biol; 2020 Nov; 39(11):1926-1937. PubMed ID: 33001759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84.
    Peters A; Rabe P; Krumbholz P; Kalwa H; Kraft R; Schöneberg T; Stäubert C
    Cell Commun Signal; 2020 Feb; 18(1):31. PubMed ID: 32102673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems.
    Reyes AWB; Kim H; Huy TXN; Vu SH; Nguyen TT; Kang CK; Min W; Lee HJ; Lee JH; Kim S
    Microb Pathog; 2021 Sep; 158():105079. PubMed ID: 34245824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages.
    Recio C; Lucy D; Purvis GSD; Iveson P; Zeboudj L; Iqbal AJ; Lin D; O'Callaghan C; Davison L; Griesbach E; Russell AJ; Wynne GM; Dib L; Monaco C; Greaves DR
    Front Immunol; 2018; 9():1419. PubMed ID: 29973940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84.
    Liu H; Zhang Q; He X; Jiang M; Wang S; Yan X; Cheng X; Liu Y; Nan FJ; Xu HE; Xie X; Yin W
    Nat Commun; 2023 Jun; 14(1):3271. PubMed ID: 37277332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists.
    Wang P; Raja A; Luscombe VB; Bataille CJR; Lucy D; Rogga VV; Greaves DR; Russell AJ
    J Med Chem; 2024 Jan; 67(1):110-137. PubMed ID: 38146625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R.
    Sundqvist M; Christenson K; Holdfeldt A; Gabl M; Mårtensson J; Björkman L; Dieckmann R; Dahlgren C; Forsman H
    Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):695-708. PubMed ID: 29477577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Biased Agonist at Immunometabolic Receptor GPR84 Causes Distinct Functional Effects in Macrophages.
    Lucy D; Purvis GSD; Zeboudj L; Chatzopoulou M; Recio C; Bataille CJR; Wynne GM; Greaves DR; Russell AJ
    ACS Chem Biol; 2019 Sep; 14(9):2055-2064. PubMed ID: 31465201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased agonists of GPR84 and insights into biological control.
    Luscombe VB; Wang P; Russell AJ; Greaves DR
    Br J Pharmacol; 2024 May; 181(10):1509-1523. PubMed ID: 38148720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
    Köse M; Pillaiyar T; Namasivayam V; De Filippo E; Sylvester K; Ulven T; von Kügelgen I; Müller CE
    J Med Chem; 2020 Mar; 63(5):2391-2410. PubMed ID: 31721581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the pro-inflammatory G protein-coupled receptor GPR84.
    Marsango S; Milligan G
    Br J Pharmacol; 2024 May; 181(10):1500-1508. PubMed ID: 37085331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands.
    Marsango S; Ward RJ; Jenkins L; Butcher AJ; Al Mahmud Z; Dwomoh L; Nagel F; Schulz S; Tikhonova IG; Tobin AB; Milligan G
    J Biol Chem; 2022 May; 298(5):101932. PubMed ID: 35427647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained wash-resistant receptor activation responses of GPR119 agonists.
    Hothersall JD; Bussey CE; Brown AJ; Scott JS; Dale I; Rawlins P
    Eur J Pharmacol; 2015 Sep; 762():430-42. PubMed ID: 26101059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.